High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Bariş and Ilknur Atabay lost their baby at birth last month. The child was buried at Bohemian National Cemetery, where 100 ...

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Eli Lilly (NYSE:LLY) is taking the unusual step of asking people who took compounded versions of their drug tirzepatide, ...

When stock markets rise, the bullish narrative tends to dominate, overlooking the potential impact of market declines. Click ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149.

The Income Suraksha plan is designed to cater to policyholders who are providing support to elderly parents or beneficiaries ...

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...